Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Insulin Adjustment Device DreaMed Endo Digital During Routine Clinical Use for Subjects With Diabetes Type 1

NCT05610722 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT05610722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05610722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Insulin Adjustment Device DreaMed Endo Digital During Routine Clinical Use for Subjects With Diabetes Type 1
Lead sponsor
Rabin Medical Center
Phase
Not applicable
Overall status
Terminated
Start date
November 6, 2022
Completion date
September 1, 2023
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes